← All companies
SBC
SBC Medical Group Holdings Incorporated
$3.16
+0.12 +3.95%
Key statistics
from XBRL data in SEC filingsMarket cap
$325M
Revenue (TTM)
$169M
Net income (TTM)
$40.8M
EPS (TTM)
$0.40
P/E ratio
7.9
Dividend yield
—
Free cash flow
$23.3M
Cash
$167M
Total assets
$388M
Gross margin
70.8%
52-week range
$2.78 – $5.07
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Delisting notice or listing-rule failure; Modified rights of security holders; Amended charter or bylaws; Shareholder vote results
Jul 14, 2026
8-K
Director or officer change
May 20, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 14, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 30, 2026
8-K
Entered a material agreement
Apr 23, 2026
10-K
Fiscal year ended 2025-12-31
Mar 27, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Mar 27, 2026
8-K
Regulation FD disclosure; Other events
Jan 5, 2026
8-K
Regulation FD disclosure; Other events
Dec 31, 2025
8-K
Other events
Dec 15, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K
Other events
Nov 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Results of operations (earnings release)
Aug 13, 2025
8-K
Regulation FD disclosure
Jul 17, 2025
8-K
Regulation FD disclosure
Jun 30, 2025
8-K
Amended charter or bylaws; Shareholder vote results
Jun 18, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 15, 2025
10-K/A
Fiscal year ended 2024-12-31
May 9, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 30, 2025
8-K
Director or officer change
Apr 2, 2025
10-K
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Results of operations (earnings release)
Mar 28, 2025
8-K
Regulation FD disclosure
Feb 18, 2025
8-K
Regulation FD disclosure
Dec 20, 2024
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Results of operations (earnings release)
Nov 13, 2024
8-K
Entered a material agreement; Completed an acquisition or disposition; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure; Other events
Sep 20, 2024
8-K
Shareholder vote results; Regulation FD disclosure
Aug 29, 2024
8-K
Regulation FD disclosure
Aug 23, 2024
10-Q
Quarter ended 2024-06-30
Aug 16, 2024
8-K
Entered a material agreement
Aug 12, 2024
10-Q
Quarter ended 2024-03-31
May 20, 2024
8-K
Delisting notice or listing-rule failure
May 8, 2024
8-K
Entered a material agreement
Apr 23, 2024
8-K
Delisting notice or listing-rule failure
Apr 4, 2024
10-K
Fiscal year ended 2023-12-31
Mar 19, 2024